Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation. [electronic resource]
Producer: 20080617Description: 237-43 p. digitalISSN:- 0300-0605
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Benzimidazoles -- pharmacology
- Benzoates -- pharmacology
- Cell Line, Tumor
- Glycation End Products, Advanced -- antagonists & inhibitors
- Humans
- Insulin -- physiology
- Insulin Resistance -- physiology
- Liver -- drug effects
- PPAR gamma -- metabolism
- Receptor, Angiotensin, Type 1 -- metabolism
- Telmisartan
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.